Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine (vol 70, pg 1509, 2020)

被引：0
|
作者：
Levin, M. J.
Weinberg, A.
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2019年 / 69卷 / 12期
关键词：
D O I：
10.1093/cid/ciz1056
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2239 / 2239
页数：1
相关论文
共 50 条
  • [11] In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : JC5 - JC5
  • [12] COST-EFFECTIVENESS ANALYSIS OF VACCINATING AGAINST HERPES ZOSTER WITH ADJUVANTED RECOMBINANT ZOSTER VACCINE IN SWITZERLAND
    Nishimwe, M. L.
    Fischer, L.
    Kientsch, U.
    Giannelos, N.
    VALUE IN HEALTH, 2022, 25 (12) : S71 - S71
  • [13] Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020
    Orru', Stefano
    Bierbaum, Sibylle
    Enk, Alexander
    Hengel, Hartmut
    Hoffelner, Marcus
    Huzly, Daniela
    Keller-Stanislawski, Brigitte
    Mahler, Vera
    Mockenhaupt, Maja
    Oberle, Doris
    EUROSURVEILLANCE, 2023, 28 (50)
  • [14] Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients
    Hirzel, Cedric
    L'Huillier, Arnaud G.
    Ferreira, Victor H.
    Marinelli, Tina
    Ku, Terrance
    Ierullo, Matthew
    Miao, Congrong
    Schmid, D. Scott
    Juvet, Stephen
    Humar, Atul
    Kumar, Deepali
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (06) : 2246 - 2253
  • [15] Safety and Immunogenicity of Adjuvanted Recombinant Subunit Herpes Zoster Vaccine in Lung Transplant Recipients
    Hirzel, C.
    Ferreira, V. H.
    L'Huillier, A. G.
    Ku, T.
    Ierullo, M.
    Miao, C.
    Schmid, D. S.
    Tikkanen, J.
    Singer, L. G.
    Humar, A.
    Kumar, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 378 - 378
  • [16] The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥ 65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
    Dagnew, Alemnew F.
    Klein, Nicola P.
    Herve, Caroline
    Kalema, George
    Di Paolo, Emmanuel
    Peterson, James
    Salaun, Bruno
    Schuind, Anne
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (07): : 1139 - 1146
  • [17] Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
    Cunningham, Anthony L.
    Heineman, Thomas C.
    Lal, Himal
    Godeaux, Olivier
    Chlibek, Roman
    Hwang, Shinn-Jang
    McElhaney, Janet E.
    Vesikari, Timo
    Andrews, Charles
    Choi, Won Suk
    Esen, Meral
    Ikematsu, Hideyuki
    Choma, Martina Kovac
    Pauksens, Karlis
    Ravault, Stephanie
    Salaun, Bruno
    Schwarz, Tino F.
    Smetana, Jan
    Vanden Abeele, Carline
    Van den Steen, Peter
    Vastiau, Ilse
    Weckx, Lily Yin
    Levin, Myron J.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (11): : 1750 - 1760
  • [18] Recombinant varicella zoster virus glycoprotein E antigen vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2021, 44 (05) : 173 - 174
  • [19] Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Fielding, James E.
    Lambert, Stephen B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16): : 1576 - 1576
  • [20] Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster
    Syed, Yahiya Y.
    DRUGS & AGING, 2018, 35 (12) : 1031 - 1040
12345